SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA
SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA Guidelines for Documentation of Stability Studies for NDAs 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for documenting stability studies for New Drug Applications (NDAs) to the United States Food and Drug Administration (US FDA)….
Read More “SOP for Documenting Stability Studies for New Drug Applications (NDAs) to the US FDA” »
